14 March 2023
To read the full version of this report, apply for our free trial
Telemedicine refers to remote consultation of healthcare practitioners. The industry is made up of two primary concepts namely, Synchronous (real-time) telemedicine and Store; and asynchronous (forward) telemedicine. Furthermore, the telemedicine industry involves patient monitoring by statistics and symptoms from a distant location.
In ASEAN, even though the virtual practice has been in play over the last few years, there is still significant untapped market potential due to the fact that many ASEAN countries are still developing their economies and this is paving way for an emerging, tech-savvy middle class who can spend more on healthcare services. There is also a significant need to bridge the healthcare gap between rural and urban areas making telemedicine an ideal solution, given the rising internet penetration in ASEAN. The focus of this report will be on the ASEAN6 countries of Singapore, Malaysia, Thailand, Vietnam, Philippines and Indonesia. Of the six regions, telemedicine development appears to be highest in Singapore with plenty of investments going into the health-tech sector. However, all six countries have plenty of growth potential since ASEAN’s telemedicine industry is still quite nascent.
The COVID-19 pandemic has provided a significant boost to the growth of the telemedicine industry, in addition to other driving factors, such as inadequate healthcare infrastructure, an aging population, and an increasing prevalence of non-communicable diseases (NCDs).
This report will provide a background on the current state of healthcare and how attractive the telemedicine sector is in ASEAN6, followed by industry drivers and the level of regulations currently enacted for telemedicine services.
1.Industry Overview
2.Driving Factors for Telemedicine
3.Regulatory Overview